1. Home
  2. KALA vs HTCR Comparison

KALA vs HTCR Comparison

Compare KALA & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$3.04

Market Cap

2.5M

Sector

Health Care

ML Signal

N/A

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$1.60

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KALA
HTCR
Founded
2009
2009
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.3M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
KALA
HTCR
Price
$3.04
$1.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 164.5K
23.3K
Earning Date
12-01-2026
11-16-2026
Dividend Yield
N/A
★ 214.88%
EPS Growth
67.39
★ 414.29
EPS
★ N/A
N/A
Revenue
N/A
★ $30,407,229.00
Revenue This Year
N/A
$118.88
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 39.19
52 Week Low
$0.07
$1.15
52 Week High
$191.00
$10.43

Technical Indicators

Market Signals
Indicator
KALA
HTCR
Relative Strength Index (RSI) 77.25 45.35
Support Level $2.07 $1.20
Resistance Level $3.71 $1.88
Average True Range (ATR) 0.14 0.17
MACD 0.38 0.00
Stochastic Oscillator 73.26 33.85

Price Performance

Historical Comparison
KALA
HTCR

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

Share on Social Networks: